Imago BioSciences’ $134.4 Million Initial Public Offering

Martina Bellini
Tagged:

Latham & Watkins LLP represented Imago BioSciences, Inc. in the offering.Imago BioSciences, Inc. (Imago) (NASDAQ: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here